Drod....I chalk this year up to pure luck....seriously. Picked the right stuff for the most part and sold and didn't worry about long term versus short term gains. NFLX....Been there done that. I went short Merrill Lynch 25 years ago in the 50's and almost got wiped out when it hit $104. Cured me from every shorting anything again. You'll recover.
Spectrollmicro.... You are totally clueless aren't you on the FDA approval process? Truly one of the dumbest and mot blantant inaccurate posts I've ever read. Seriously. You can't get approval without first getting an agreed upon trial protocol agreement with the FDA called a SPA. Siga hasn't even gotten that far. In fact, I doubt if they're even past very preliminary discussions with the FDA on a SPA for ST-246. Why do people like you lie on a message board? Or are you just simply stupid? Which one is it?
Henry....No...I actually took it all out at a $27 plus average. Looking to get back into it though
however much lower frankly. Still like the company and it's prospects alot!
ONTX...Sold this morning at $14.50...Took the 3.5 pt loss. Need it this year after TSRX and RLYP doubled, DRTX.TTPH,SRPT, and some others were big winners for me. Been a very good year in the bios thankfully.
Next one will be KPTI if it ever trades back into the mid to higher teens.
ONTX lead their IPO out with a very high risk pancreatic cancer indication which was a 10:1 shot to begin
with. Should have put that trial on the back burner after they got a winner like MDS could be. At least the odds are far better with that one. You don't lead with a longshot loser. Management is obviously inept which is another reason I dumped it. One inept management holding is enough for me!
Tween....no...I have 15k of Siga at $2.92. I think Parson's will want to stick it to Siga again but in a way that would hold up on any appeal. But as a longshot he could come to the logical conclusion that expectation damages at the time of breach were nominal,and simply award those and blame it on the Supreme Court!
In bios I'm looking to get into KPTI on any pullback into the 18's...Bio and high risk, but looks darn
interesting frankly. GL!
Took a 4 pt loss but that's better than it is now. Looked at that opening today as a gift from Manna.
Really didn't like the way management has guided this company. Throwing away IPO money, not to mention
some very bad PR and decline in stock value, on a very high risk probability of success (pancreatic cancer) indication, before at least "hitting" on one (MDS), is amateur hour, and simply foolish. Get some winners first, then go into the higher risk applications. Not vice versa. Simply stupid. In MBA school that strategy would garner an "F"...Seriously.
Orphan drug is the classification of the market for which the drug addresses. Small potential markets are classified as "Orphan Drugs". "Fast track" is the procedure to expediiteFDA approval of a drug, Apples and
Just read the ML report. Looks very interesting....Will wait for some type of pullback though...
It was $16 in November before they reported some good results at ASH. Looks like there still could be some tolerability issues though.....
Given the said state of both companies, and especially PIP, and the fact PIP may never see a dime from
their "win" regardless of the outcome, I would think PIP would take 20 mil right now and walk away...No, make that run away. Time is on Siga's side. All they have to do is legally wait for PIP to go under (and that is perhaps coming faster than anyone might expect here) and the game is over...
Thanks guys for the well thought out comments.
ONTX's venture into pancreatic was not purely for humanitarian purposes, so we need to be
clear on that issue. It was a #$%$ shoot that would have paid off 10,000:1 had it worked.
It didn't. In retrospect it was a waste of the company's limited financial resources that
could have been spent in a different direction. The timing of the release couldn't have been
worse, but it was such a material event they really had no option. Like I said earlier, challenging
indications would have been better served after the company established a marketable drug.
This was just plain stupid. So now it is totally make or break on MDS. Strike out there this company
is toast. If pancreatic was still in the fire a failed MDS trial would not by itself wiped out the
The analysts need to question management on where their heads are right now.
They're running a public company for goodness sakes. Money is an issue.
So is success.
Yes...pancreatic is very difficult to treat no doubt about it. Therefore it seems like a bad management call
to have this one first out of the box following an IPO where the stock has gone from 31 to a new low tomorrow morning. Better to have put pancreatic on the back burner first, and lead with our best shot, Metastatic.
How did they think the investment community would take a halted trial? Positively? Dumb.
AMLN...If you like GLD go long ABX...Nice article in Barrons a few weeks ago on them. I recently went
fairly large into ABX at $15.35. Think we will see $24-$25 on it in 2014. GL
evenu2canbeamoronlikeme....Come on man...get a grip. You sound like the biggest pansy #$%$ I've
ever heard. Try getting laid, drugs, alcohol, or maybe a combination of all the above. You've lost it. You one big nut job..Get some professional help, and SOON!
Beav....Right now no way IMHO for Siga to be scooped up by anyone. Until the lawsuit is final, a potential buyer has no idea of what they'd actually be buying. Inturn, it would make more sense frankly for RP...Rose...et al. to see a huge final judgment entered in favor of PIP, then for Siga to BK that judgment out.
PIP would get nothing...Siga shareholders would also be wiped out....But RP and his team, or his nominees,
could buy the rights and patents for ST-246 out of Bankruptcy for pennies on the dollar... They then could form a new private company....basically keep the same "team" in place, and resume their relationship with BARDA, without interference from PIP, or any other unsecured creditor left over from Siga. If I were representing them, and Siga got hit with a big fat final judgment in favor of PIP, that's exactly what I'd tell them to "strongly" consider.
Wishing failure of this drug so the stock will decline in price and you will profit therefrom, is wishing those who are inflicted with this disease, infirmity, pain, and eventually, death. About the worst form of bad karma one could conceivably imagine.
With 1,000s of stock that you could short, to short and wish bad fortune on this one, is just asking for trouble, especially at Christmas time when so many are in pain and suffering. Whether you believe in a supreme being or not, or even an after life at all, I would urge you to rethink your sentiments during this Holiday Season.